Biomarkers and Cancer

Discover how expanding testing databases can unveil significant biomarkers linked to conditions like hypothyroidism and colorectal cancer. By analyzing the magnitude of change in metabolites, insights emerge about potential risks and trends, challenging the notion of normative ranges in clinical assessments. The discussion highlights the importance of alpha ketoglutarate, a molecule often touted for its anti-aging properties, in the context of cancer risk.